QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,500 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Mr. Douglas Bryant is the President of QuidelOrtho Corp, joining the firm since 2009.
What is the price performance of QDEL stock?
The current price of QDEL is $10.85, it has increased 0.46% in the last trading day.
What are the primary business themes or industries for QuidelOrtho Corp?
QuidelOrtho Corp belongs to Health Care industry and the sector is Health Care
What is QuidelOrtho Corp market cap?
QuidelOrtho Corp's current market cap is $738.6M
Is QuidelOrtho Corp a buy, sell, or hold?
According to wall street analysts, 8 analysts have made analyst ratings for QuidelOrtho Corp, including 4 strong buy, 6 buy, 4 hold, 1 sell, and 4 strong sell